Table 1. CI values for the synergistic effect of AEW541 and chemotherapeutic drugs.
Cells | Drug | Drug Dose (uM × 10) | Dose AEW(uM) | Effect | Cl | Synergism |
---|---|---|---|---|---|---|
0.5 | 0.59 | 0.24 | Strong | |||
rinotecan | 1.0 | 1.5 | 0.71 | 0.17 | Strong | |
5.0 | 0.83 | 0.31 | Synergism | |||
0.5 | 0.92 | 0.01 | Very strong | |||
Gemcitabine | 1.0 | 0.95 | 0.00 | Very strong | ||
10.0 | 0.93 | 0.04 | Very strong | |||
0.1 | 0.67 | 0.56 | Synergism | |||
Taxol | 0.5 | 0.85 | 0.40 | Synergism | ||
MCF7 | 1.0 | 0.85 | 0.77 | Moderate | ||
5.0 | 0.75 | 0.37 | Synergism | |||
Cisplatin | 10.0 | 2.0 | 0.83 | 0.26 | Strong | |
20.0 | 0.85 | 0.36 | Synergism | |||
0.5 | 0.71 | 0.29 | Strong | |||
VP-16 | 1.0 | 0.78 | 0.14 | Strong | ||
10.0 | 0.85 | 0.06 | Very strong | |||
0.1 | 0.73 | 0.18 | Strong | |||
Doxorubicin | 1.0 | 0.81 | 0.14 | Strong | ||
2.0 | 0.83 | 0.16 | Strong |
Values under Effect (fifth column) denote the proportion of cells that were killed by the combination treatment.